RT Journal Article
SR Electronic
T1 Multi-trait genetic analysis identifies novel pleiotropic loci for depression and schizophrenia in East Asians
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.30.24301991
DO 10.1101/2024.01.30.24301991
A1 Song, Yingchao
A1 Li, Linzehao
A1 Jiang, Yue
A1 Peng, Bichen
A1 Jiang, Hengxuan
A1 Chao, Zhen
A1 Chang, Xiao
YR 2024
UL http://medrxiv.org/content/early/2024/03/01/2024.01.30.24301991.abstract
AB While genetic correlations, pleiotropic loci, and shared genetic mechanisms of psychiatric disorders have been extensively studied in European populations, the investigation of these factors in East Asian populations has been relatively limited. To identify novel pleiotropic risk loci for depression and schizophrenia (SCZ) in East Asians. We harnessed the most comprehensive dataset available for East Asians and quantified the genetic overlap between depression, SCZ, and their related traits via LD Score regression (LDSC) analyses. Besides the correlation between depression and SCZ, our analysis revealed significant genetic correlations between depression and obesity-related traits, such as weight, BMI, T2D, and HDL. In SCZ, significant correlations were detected with HDL, heart diseases and use of various medications. Conventional meta-analysis of depression and SCZ identified a novel locus at 1q25.2 in East Asians. Moreover, this locus was verified in the multi-trait analysis of GWAS (MTAG), which can improve the statistical power of single-trait GWAS by incorporating information from effect estimates across genetically correlated traits. Furthermore, multi-trait analysis of depression, SCZ and related traits identified ten novel pleiotropic loci for depression, and four for SCZ. Our findings demonstrate shared genetic underpinnings between depression and SCZ in East Asians, as well as their associated traits, providing novel candidate genes for the identification and prioritization of therapeutic targets specific to this population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by the Special Funds of Taishan Scholar Project, China (tsqn202211224)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://www.ebi.ac.uk/gwas/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors